![Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin® | Mylan N.V. Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin® | Mylan N.V.](http://mma.prnewswire.com/media/468734/Mylan_Logo.jpg)
Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin® | Mylan N.V.
![$800 Billion Investor Group Launches “VOTE NO” Campaign Against Board and Executive Pay at EpiPen-Maker Mylan : Office of the New York City Comptroller Brad Lander $800 Billion Investor Group Launches “VOTE NO” Campaign Against Board and Executive Pay at EpiPen-Maker Mylan : Office of the New York City Comptroller Brad Lander](https://comptroller.nyc.gov/wp-content/uploads/2017/05/mylan_shutterstock_476039440.jpg)
$800 Billion Investor Group Launches “VOTE NO” Campaign Against Board and Executive Pay at EpiPen-Maker Mylan : Office of the New York City Comptroller Brad Lander
![Biocon Biologics and Mylan Announce Launch of Semglee in the U.S. to Expand Access for Patients Living with Diabetes | World Pharma Today Biocon Biologics and Mylan Announce Launch of Semglee in the U.S. to Expand Access for Patients Living with Diabetes | World Pharma Today](https://www.worldpharmatoday.com/wp-content/uploads/press-releases/15044/Biocan_Mylan.jpg)